These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36170802)

  • 1. The prevalence of thrombocytopenia in patients with acute cancer-associated thrombosis.
    Hsu C; Patell R; Zwicker JI
    Blood Adv; 2023 Sep; 7(17):4721-4727. PubMed ID: 36170802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort.
    Houghton DE; Key NS; Zakai NA; Laux JP; Shea TC; Moll S
    Leuk Lymphoma; 2017 Nov; 58(11):2573-2581. PubMed ID: 28393576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of anticoagulation in thrombocytopenic patients with hematologic malignancies: A case series.
    Campbell PM; Ippoliti C; Parmar S
    J Oncol Pharm Pract; 2017 Apr; 23(3):220-225. PubMed ID: 26854266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes.
    Samuelson Bannow BT; Walter RB; Gernsheimer TB; Garcia DA
    J Thromb Thrombolysis; 2017 Nov; 44(4):442-447. PubMed ID: 28884390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet transfusion and anticoagulation in hematological cancer-associated thrombosis and thrombocytopenia: The CAVEaT multicenter prospective cohort.
    Booth S; ; Desborough M; Curry N; Stanworth S
    J Thromb Haemost; 2022 Aug; 20(8):1830-1838. PubMed ID: 35505495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation management and related outcomes in patients with cancer-associated thrombosis and thrombocytopenia: A systematic review and meta-analysis.
    Wang TF; Carrier M; Carney BJ; Kimpton M; Delluc A
    Thromb Res; 2023 Jul; 227():8-16. PubMed ID: 37196605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study.
    Carney BJ; Wang TF; Ren S; George G; Al Homssi A; Gaddh M; Connolly GC; Shah VI; Bogue T; Bartosic A; Neuberg D; Baumann Kreuziger L; Zwicker JI;
    Blood Adv; 2021 Dec; 5(24):5546-5553. PubMed ID: 34662892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study.
    Baumann Kreuziger L; Gaddh M; Onadeko O; George G; Wang TF; Oo TH; Jaglal M; Houghton DE; Streiff MB; Gali R; Feng M; Simpson P; Billett HH
    Thromb Res; 2021 Jun; 202():155-161. PubMed ID: 33862470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia.
    Khanal N; Bociek RG; Chen B; Vose JM; Armitage JO; Bierman PJ; Maness LJ; Lunning MA; Gundabolu K; Bhatt VR
    Am J Hematol; 2016 Nov; 91(11):E468-E472. PubMed ID: 27489982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival patterns among venous thromboembolism patients with hematologic malignancies in Alberta, Canada from 2003 to 2015.
    Alam AU; Karkhaneh M; Sun HL; Wu C
    Thromb Res; 2021 Mar; 199():59-66. PubMed ID: 33429125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of enoxaparin treatment in venous thromboembolic disease during acute leukemia.
    Imberti D; Vallisa D; Anselmi E; Moroni CF; Bertè R; Lazzaro A; Bernuzzi P; Arcari AL; Cavanna L
    Tumori; 2004; 90(4):390-3. PubMed ID: 15510981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study.
    Squizzato A; Galliazzo S; Rancan E; Di Pilla M; Micucci G; Podda G; Valeriani E; Campiotti L; Bertù L; Ageno W; Porreca E; Lodigiani C
    Intern Emerg Med; 2022 Jan; 17(1):83-90. PubMed ID: 34110563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Cancer-Associated Venous Thromboembolism in Patients With Solid and Hematologic Neoplasms in the Veterans Affairs Health Care System.
    Martens KL; Li A; La J; May SB; Swinnerton KN; Tosi H; Elbers DC; Do NV; Brophy MT; Gaziano JM; Lotfollahzadeh S; Chitalia V; Ravid K; Fillmore NR
    JAMA Netw Open; 2023 Jun; 6(6):e2317945. PubMed ID: 37306999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.
    Al-Samkari H; Connors JM
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):71-79. PubMed ID: 31808892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients.
    Junqueira DR; Perini E; Penholati RR; Carvalho MG
    Cochrane Database Syst Rev; 2012 Sep; (9):CD007557. PubMed ID: 22972111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of Cancer-Associated Venous Thromboembolism Is More Favorable among Patients with Hematologic Malignancies than in Those with Solid Tumors.
    Lecumberri R; Ruiz-Artacho P; Tzoran I; Brenner B; Farge-Bancel D; Ay C; Rosa V; Francisco I; Hernández-Blasco LM; Trujillo-Santos J; Monreal M;
    Thromb Haemost; 2022 Sep; 122(9):1594-1602. PubMed ID: 35189661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries.
    Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Schein J; Kaatz S
    J Manag Care Pharm; 2012 Jun; 18(5):363-74. PubMed ID: 22663169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of anticoagulation in the treatment of venous thromboembolism in patients with haematological malignancies and thrombocytopenia: Report of 5 cases and literature review.
    Lim MS; Enjeti AK
    Crit Rev Oncol Hematol; 2016 Sep; 105():92-9. PubMed ID: 27397486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation for people with cancer and central venous catheters.
    Kahale LA; Tsolakian IG; Hakoum MB; Matar CF; Barba M; Yosuico VE; Terrenato I; Sperati F; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006468. PubMed ID: 29856471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Prophylactic Heparin Dosage Strategies and Risk Factors for Venous Thromboembolism in the Critically Ill Patient.
    Reynolds PM; Van Matre ET; Wright GC; McQueen RB; Burnham EL; Ho PJM; Moss M; Vandivier RW; Kiser TH;
    Pharmacotherapy; 2019 Mar; 39(3):232-241. PubMed ID: 30592541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.